cellvie secures $5 Million in fresh capital from existing and new investors
Zurich, Switzerland – September 9th, 2025 – cellvie, a company pioneering therapeutics based on mitochondria, today announced the closing of a $5 million funding round, with participation from both existing and new investors. The round was led by Taiho Ventures,... Read More →
Koya Medical Receives “Building Tomorrow Together” Award from Dallas Regional Chamber
Innovative vascular health company recognized for commitment to growth, innovation, and community impact in North Texas DALLAS, Sept. 9, 2025 /PRNewswire/ — Koya Medical (“Koya”), a global leader in vascular health innovation, is proud to announce it has been honored... Read More →
MY01 Welcomes Joe Kiani as Investor and Board Member to Accelerate Innovation in Connected Patient Monitoring
MONTREAL, Sept. 8, 2025 /PRNewswire/ — MY01, an innovative medical technology company focused on transforming the diagnosis of limb perfusion injuries, today announced that Joe Kiani, founder of Masimo and a globally recognized leader in medical innovation, has invested in... Read More →
Cerillo to launch Rayo: Next-Gen Multiwavelength Microplate Reader at Analytica USA 2025
CHARLOTTESVILLE, Va., Sept. 8, 2025 /PRNewswire/ — Cerillo, pioneer in compact microplate reader technology, is proud to announce the launch of Rayo, its newest multiwavelength platform for ELISA assays, protein quantification, and kinetic growth curves for plant, algae, and microbial... Read More →
OrthoPediatrics Corp. Announces Distribution Agreement with MY01 Inc.
WARSAW, Ind., Sept. 05, 2025 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics announced today a new distribution partnership with MY01, an innovative medical technology company focused on transforming the... Read More →
Edwards buys remaining stake of Vectorious Medical Technologies and its heart implant
According to a report in Globes, Edwards Lifesciences (NYSE: EW)+ agreed to acquire the remaining stake in Vectorious Medical Technologies. The report states that Edwards’ deal values Vectorious at $497 million. It executed the acquisition in two stages, the report... Read More →
Ways to Improve Osteopenia with Osteoboost
It is exciting when new products come to market that speak directly to our demographic. Our guest this week, is Laura Yecies, CEO of Osteoboost. Osteoboost is the first FDA-cleared drug-free prescription treatment for osteopenia in postmenopausal women. How does... Read More →
PacBio and EpiCypher Partner to Deliver Novel Insights into Epigenomics with Fiber-seq Workflow
New addition to PacBio Compatible program enables scientists to connect genetic variation with gene regulation in a single assay, advancing research in rare disease and cancer MENLO PARK, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading... Read More →
Nutromics banks A$7.5m to make its ‘lab-on-a-patch’ device in Australia
Melbourne medtech startup Nutromics has raised A$7.5 million in an acceleration round, taking total funding to about A$60 million. Nutromics is developing a wearable “lab-on-a-patch” device that uses DNA biosensors and microneedles to capture continuous, real-time molecular data. “Our world... Read More →
Inflammatix Data in Journal of Clinical Microbiology Validate Accuracy, Robustness, and Ease of Use of TriVerity™ Test System
Publication demonstrates superior analytical performance of TriVerity in assessing patients with suspected acute infection or sepsis SUNNYVALE, Calif., Sept. 2, 2025 /PRNewswire/ — Inflammatix, a pioneering host response diagnostics company, today announced the publication of analytical data in the Journal... Read More →